Dec. 28 at 11:49 PM
$CYAN Really encouraging to see Cyanotech's turnaround progress lately. The latest quarter had net sales up over 10% year-over-year, gross margins hitting 35%, and the operating loss down to just
$50K from
$848K last year. Shows their cost controls and production efficiencies are paying off with their premium Hawaiian astaxanthin (BioAstin) and spirulina. Staying optimistic on the long-term story here. Anyone else watching CYAN closely?